Full Breakdown
Progress in Kidney Transplant Equity for Black Patients
3/10/2026, 2:43:49 AM
Positive Outcomes from Policy Changes
Recent changes in U.S. kidney transplant policies have led to significant improvements for Black patients suffering from kidney disease. A report published in JAMA Internal Medicine indicates that Black patients are receiving more transplants and spending less time on waiting lists due to the removal of race-based medical guidelines that previously hindered their access to care. Dr. Rohan Khazanchi, the study leader from Brigham and Women’s Hospital and Boston Medical Center, stated, “Our findings indicate that reparative approaches to address the harms caused by race-based clinical algorithms can help move the needle toward health equity.”
Historically, Black patients required worse renal function than their white counterparts to receive a diagnosis of kidney disease. In 2021, the U.S. healthcare system removed race from equations used to estimate renal function, prompting hospitals to reassess the status of Black patients on transplant waiting lists. As of June 2025, over 21,000 Black patients had their waiting times adjusted, resulting in an increase of 5.3 transplants per 1,000 Black candidates without affecting the transplant rates of non-Black patients.
Background on Racial Disparities in Kidney Care
The previous race-based formula for assessing kidney function was rooted in flawed assumptions about biological differences in creatinine levels. This method exacerbated existing disparities, as Black Americans are over three times more likely than white individuals to experience kidney failure, yet they represent about 30% of the kidney transplant waiting list. The policy changes aimed to rectify these inequities by providing Black patients with credit for time lost due to the biased assessments.
Criticism of the Current System
Despite the positive changes, there remains a significant gap in equitable treatment. Dr. Khazanchi noted that less than one-third of Black transplant candidates received wait-time modifications, potentially due to late diagnoses or disparities in resources among transplant centers. Some patients may not have been diagnosed until they required emergency dialysis, complicating their eligibility for timely transplants.
Official Statements on the Findings
Dr. L. Ebony Boulware from Wake Forest University School of Medicine, who was not involved in the study, commented that the findings “suggest that improving transplant care for Black individuals did not harm individuals of other races.” This sentiment reflects a broader hope that similar efforts can be applied to other areas of healthcare where race-based biases persist.
Verbatim Quotes
- “Our findings indicate that reparative approaches to address the harms caused by race-based clinical algorithms can help move the needle toward health equity,” — Dr. Rohan Khazanchi, Brigham and Women’s Hospital and Boston Medical Center
- “The policy “hopefully helps move the needle toward equity,” Dr.” — Dr. Rohan Khazanchi
- “suggest that improving transplant care for Black individuals did not harm individuals of other races,” — Dr. L. Ebony Boulware, Wake Forest University School of Medicine
What's Next for Kidney Transplant Equity?
As the healthcare system continues to evaluate and adjust policies, ongoing monitoring and intervention will be essential to ensure that all communities are equitably prioritized in kidney transplant procedures. The recent changes represent a step forward, but further efforts are needed to address the remaining disparities in kidney care for Black patients.
